Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.

Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F.

J Clin Pathol. 2002 Dec;55(12):900-5.

PMID:
12461053
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG.

Cancer. 2000 Apr 1;88(7):1663-70.

PMID:
10738225
[PubMed - indexed for MEDLINE]
5.

Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.

Mamoon N, Iqbal MA, Jamal S, Luqman M.

J Ayub Med Coll Abbottabad. 2006 Apr-Jun;18(2):4-8.

PMID:
16977804
[PubMed - indexed for MEDLINE]
6.
7.

Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.

Quintero A, Alvarez-Kindelan J, Luque RJ, Gonzalez-Campora R, Requena MJ, Montironi R, Lopez-Beltran A.

J Clin Pathol. 2006 Jan;59(1):83-8.

PMID:
16394286
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y, Tong S, Xia G, Fang Z, Ding Q.

PLoS One. 2012;7(10):e47199. doi: 10.1371/journal.pone.0047199. Epub 2012 Oct 17.

PMID:
23082147
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.

Pich A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Navone R.

Am J Surg Pathol. 2001 Dec;25(12):1528-33.

PMID:
11717543
[PubMed - indexed for MEDLINE]
10.
11.

Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.

Campbell PA, Conrad RJ, Campbell CM, Nicol DL, MacTaggart P.

BJU Int. 2004 Jun;93(9):1228-31.

PMID:
15180612
[PubMed - indexed for MEDLINE]
12.

Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder.

Krüger S, Thorns C, Böhle A, Feller AC.

Int Urol Nephrol. 2003;35(2):169-73.

PMID:
15072488
[PubMed - indexed for MEDLINE]
13.

Recurrence and progression in low grade papillary urothelial tumors.

Holmäng S, Hedelin H, Anderström C, Holmberg E, Busch C, Johansson SL.

J Urol. 1999 Sep;162(3 Pt 1):702-7.

PMID:
10458347
[PubMed - indexed for MEDLINE]
14.

Histologic grading of urothelial carcinoma: a reappraisal.

Cheng L, MacLennan GT, Lopez-Beltran A.

Hum Pathol. 2012 Dec;43(12):2097-108. doi: 10.1016/j.humpath.2012.01.008. Epub 2012 Apr 26.

PMID:
22542126
[PubMed - indexed for MEDLINE]
16.

Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma.

Bircan S, Candir O, Serel TA.

Urol Int. 2004;73(3):201-8.

PMID:
15539837
[PubMed - indexed for MEDLINE]
17.

Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.

Yorukoglu K, Tuna B, Dikicioglu E, Duzcan E, Isisag A, Sen S, Mungan U, Kirkali Z.

Virchows Arch. 2003 Dec;443(6):734-40. Epub 2003 Oct 8.

PMID:
14534785
[PubMed - indexed for MEDLINE]
18.

Evaluation of p53 nuclear accumulation in low- and high-grade (WHO/ISUP classification) transitional papillary carcinomas of the bladder for tumor recurrence and progression.

Vardar E, Gunlusoy B, Minareci S, Postaci H, Ayder AR.

Urol Int. 2006;77(1):27-33.

PMID:
16825812
[PubMed - indexed for MEDLINE]
19.

Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.

Chang WC, Chang YH, Pan CC.

Am J Surg Pathol. 2012 Mar;36(3):454-61. doi: 10.1097/PAS.0b013e31823dafd3.

PMID:
22261706
[PubMed - indexed for MEDLINE]
20.

Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.

Holmäng S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL.

J Urol. 2001 Apr;165(4):1124-8; discussion 1128-30.

PMID:
11257652
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk